Merck MRK
Merck Announces Third-Quarter 2023 Financial Results
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001104659-23-111585
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Abbott Laboratories ABT public float $232.2B, Jun 30, 2025
- Amgen AMGN public float $150.1B, Jun 30, 2025
- Pfizer PFE public float $138.0B, Jun 29, 2025
- AbbVie ABBV public float $325.1B, Jun 30, 2025
- Vertex Pharmaceuticals VRTX public float $113.4B, Jun 30, 2025
